Singapore’s ClavystBio backs UK biotech Cirrus...

Ajouter une nouvelle offre d'emploi Health

2025-10-03 04:39:34 -

Singapore’s ClavystBio backs UK biotech Cirrus Therapeutics’s $11M funding

Cirrus Therapeutics, an United Kingdom-based ocular immunology-focused biotech, announced Wednesday the close of an $11 million seed financing to advance its pipeline of gene and cell therapies aimed at improving quality of life and extending the ocular healthspan of patients with chronic blinding diseases. The round was led by ClavystBio, with participation from Polaris Partners and SEEDS,...

0 Commentaires 0 Parts 293 Vue 0 Aperçu